Healthcare has a well-developed market structure supportive of new company creation. This dynamism, as well as diversity of companies serving the healthcare market, provides ample opportunities to capitalize on the accelerating pace of innovation and corresponding scientific breakthroughs in the life sciences.
sECTOR SPECIALTIES
NicHealth
why invest in HEALTHCARE
our edge
Why NicHealth
Focus: Target companies that are developing novel solutions that address unmet medical needs or advance an under-served market
Insights: Apply an operator’s framework to evaluate business models, go-to-market strategies, and valuation of prospective portfolio companies
Discipline: Specialize and conduct extensive fundamental research to gain conviction in both our public and private investments
Alignment: Invest alongside clients and constrain capacity to maintain flexibility to invest in smaller cap, emerging technology
Experience: Financial market and industry-operator background distinctly qualifies us to assess opportunities and risks
Insights: Apply an operator’s framework to evaluate business models, go-to-market strategies, and valuation of prospective portfolio companies
Discipline: Specialize and conduct extensive fundamental research to gain conviction in both our public and private investments
Alignment: Invest alongside clients and constrain capacity to maintain flexibility to invest in smaller cap, emerging technology
Experience: Financial market and industry-operator background distinctly qualifies us to assess opportunities and risks
inception date
January 1, 2017
NICHOLAS INVESTMENT PARTNERS
Investment Approach
NicHealth is a sector-focused strategy which seeks to capitalize on the accelerating pace of innovation and corresponding scientific breakthroughs in the life sciences industry. Using the firm’s core investment pillars, the strategy emphasizes innovation, emerging technologies, and novel business. With an emphasis on development-stage and near commercial-stage companies, the strategy offers exposure to those sub-sectors experiencing the most rapid advancements, including biotechnology, life science tools & diagnostics, digital health, and synthetic biology, while benefiting from a diversified set of return drivers. The portfolio is typically comprised of 30 to 50 healthcare-related securities, diversified across life sciences ecosystem, both long and short, and hedges downside market risk through hedging strategies.
Driver of Expected Return
Bottom up, research-driven stock selection. Industry weights and factor exposures are a residual of the stock-selection process.
LEAD PORTFOLIO MANAGER
Lisa Wheatley